| NCT02490657 |
Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490618 |
The Use of a Probiotic Lozenge in the Treatment of Residual Pockets After Classical Non-surgical Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490605 |
Effect of the Use of an Occlusal Plate on the Postural Alignment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490592 |
Comparison of the Effect of Fluoride Remineralizer Gel and Foam |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490566 |
Enhanced Primary Care and Technology for Children With Chronic Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490358 |
Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490332 |
The Effects of Ventilation Tubes - The SIUTIT Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490293 |
Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490267 |
Quality of Life in Children Glaucoma and Cataract |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490202 |
Efficacy and Safety of SANGUINATE⢠for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490150 |
Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490059 |
Ultrathin Bronchoscopy for Solitary Pulmonary Nodules |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490033 |
The VERISMART Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02490020 |
A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489994 |
Performance of the ePrime System for Cellulite |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489968 |
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489903 |
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489851 |
Quadratus Lumborum Block vs Tranversus Abdominis Plane Block for Cesarean Section |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489760 |
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489734 |
Post Extubation Delirium and End-tidal Sevoflurane Concentration |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489695 |
Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489669 |
Renal Insufficiency Following Contrast Media Administration Trial III |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489656 |
Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489604 |
Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489461 |
Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489435 |
Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489357 |
Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489318 |
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489305 |
Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489292 |
Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489266 |
In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489227 |
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489058 |
A Study of Long-Term Responders on Olaparib |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489032 |
Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Refer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02489006 |
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488993 |
Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488967 |
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488902 |
A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488850 |
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488759 |
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488733 |
Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488720 |
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488694 |
Maintaining ERBB Blockade in EGFR-mutated Lung Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488668 |
Surface Electrical Stimulation for Treatment of Phantom Limb Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488616 |
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488603 |
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488551 |
A Computer-Assisted CBT Tool to Enhance Fidelity in CBOCs |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488512 |
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488460 |
Effects of Physical Activity on Math - an RCT |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488434 |
The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488395 |
Superior Colliculus Activity in Parkinson Disease: a Potential Marker? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488369 |
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488356 |
Litramine for Weight Loss |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488304 |
Prospective Study for Transplant Optimization Using Functional Imaging (TROFI) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488161 |
Factors Related to Adverse Events in Colorectal Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488135 |
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488057 |
Improving Beta Cell Function in Mexican American Women With Prediabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488018 |
Investigation of the Glycemic Index of Ethiopian Honey |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02488005 |
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487992 |
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487966 |
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487758 |
Ridge Preservation Comparing the Clinical and Histologic Healing of Flap vs. Flapless Approach to Grafting |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487732 |
Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487693 |
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487667 |
Therapeutic Exercise Training in the Elderly |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487628 |
Evaluation of HQĀ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487602 |
A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487550 |
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487459 |
Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487433 |
A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487420 |
Gradual Egg-tolerance Induction in Hen's Egg Allergic Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487394 |
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487368 |
Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487303 |
Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487251 |
Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschools |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487212 |
Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487160 |
Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487134 |
Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487095 |
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487069 |
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487056 |
Patient Journey in Hospital With Heart Failure in Turkish Population |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02487004 |
The Study of Association Between Intradialysis Sodium Balance and Clinical Outcomes in Chronic Hemodialysis Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486861 |
OCT-Features in Culprit and Not Culprit Coronary Plaque in ACS Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486835 |
Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486757 |
Investigation of Female Reproductive Hormone Dynamics During Adolescence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486718 |
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486705 |
Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486692 |
Pilot Evaluation of AboutFace: Novel Peer Education Resource for Veterans |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486666 |
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486458 |
Long-term Release of Fluoride Formed on Enamel by Fluoride Gel or Varnish to Biofilm Fluid |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486432 |
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral SinemetĀ® (Levodopa/Carbidopa) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486393 |
Complications in Parotid Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486367 |
Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486302 |
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486250 |
Online Neuropsychological Test Validation Project With Imaging Pilot |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486159 |
The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486133 |
Dual Therapy With Boosted Darunavir + Dolutegravir |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486120 |
Are Genetic Counselors Screening for Adolescent Suicide Risk? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486094 |
Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486068 |
ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02486003 |
Testing mTBI in Athletes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485951 |
Central Versus Peripheral Air Injection for DALK (Deep Anterior Lamellar Keratoplasty) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485860 |
Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485834 |
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485795 |
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485769 |
Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485756 |
Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485704 |
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485561 |
Evaluating Strategies to Present Colon Cancer Screening Information |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485535 |
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485457 |
Validation of Nicom Device to Measure Stoke Volume Variation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485418 |
Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485405 |
Gut Permeability and Stress |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485392 |
A Comparison of Robot-assisted Single Site and Laparoscopic Single-incision Cholecystectomy for Benign Gallbladder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485366 |
Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485158 |
Individual Differences in the Response to Drugs |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485132 |
Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485106 |
Rifaximin Use in Severe Alcoholic Hepatitis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485093 |
To Pace or Not to Pace in Sinus Node Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485067 |
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485028 |
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02485002 |
Differences in Urine NGAL Levels in Patients Undergoing RIRS With or Without Ureteral Access Sheath |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484950 |
Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484859 |
Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484833 |
Erbitux MEtastatic Colorectal Cancer Strategy Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484820 |
Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484794 |
Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484768 |
IV Iron Treatment of Restless Legs Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484703 |
A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484651 |
Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484560 |
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484534 |
Thrombin Generation Test in Patient With Liver Cirrhosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484495 |
Extended Pilot Project Community Based Production of Complementary Food in Ethiopia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484469 |
Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484456 |
Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484404 |
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484300 |
The Effect of Melatonin on Sleep and Ventilatory Control in Obstructive Sleep Apnea |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484261 |
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484235 |
Effects of High Intensity Interval Training and Strength Training in Obese |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484157 |
Comparison of ACT Between Hemochron Jr and ACT Plus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484118 |
Hemodialysis Blood Flow and Urea Clearance |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484105 |
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484092 |
A Gene Therapy Study for Hemophilia B |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02484066 |
VBN-EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLs |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483858 |
Study of Oral PQR309 in Patients With Advanced Solid Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483832 |
Message Framing and Colorectal Cancer Screening |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483806 |
Effects of Positive End-Expiratory Pressure on Biventricular Function During One-Lung Ventilation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483793 |
Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483767 |
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483702 |
Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483650 |
Hyperbaric Oxygen Therapy Registry |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483559 |
Seeing the World Through Assorted Glasses |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483533 |
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483520 |
Supporting Family Caregivers With Technology for Dementia Home Care |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483494 |
Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483468 |
The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483403 |
Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483351 |
Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483312 |
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483260 |
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483234 |
Psoriasis-Arthritis & Bone Program |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483195 |
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483169 |
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483156 |
Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02483104 |
Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482961 |
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482935 |
A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482857 |
Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482818 |
Efficacy of Pregabalin on Chronic Cough |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482805 |
Hormones and Social Anxiety Disorder Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482792 |
Norwegian Psychomotor Physiotherapy in Patients With Long-lasting Musculoskeletal Pain. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482766 |
Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482558 |
Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482532 |
Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482493 |
All Polyethylene Versus Metal Backed Tibial Components in Knee Replacement |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482467 |
Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482402 |
Iloprost for Bridging to Heart Transplantation in PH |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482350 |
App-delivered Therapy for Arabic Readers With Hemianopic Alexia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482259 |
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482233 |
The END Perioperative Smoking Pilot Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482220 |
Physical Activity Program and Energy Intake Control in Obese Adolescents |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482194 |
Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482168 |
Study of the CD40 Agonistic Monoclonal Antibody APX005M |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482103 |
The Dutch National Renal Denervation Registry |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02482051 |
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481960 |
Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481934 |
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481895 |
Efficacy of an Innovative E-neurocognitive Module for Bipolar Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481869 |
Platelet Rich Plasma Injection in Pilon Fractures |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481856 |
A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481804 |
Optimal Feeding for NET Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481661 |
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481635 |
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481557 |
Effects of an Oxalate Containing Product on Dentinal Hypersensitivity With Dental Prophylaxis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481518 |
Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481505 |
Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481492 |
Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Technique |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481466 |
The Combined Portfolio Diet and Exercise Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481258 |
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT02481232 |
A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|